163 Treatment with gonadotrophin-releasing hormone at the time of AI in beef heifers that fail to express oestrus after an estradiol-based synchronisation protocol improves pregnancies per AI

2020 ◽  
Vol 32 (2) ◽  
pp. 208
Author(s):  
A. Butler ◽  
H. Butler ◽  
G. Cesaroni ◽  
R. Alberio ◽  
S. Perez Wallace ◽  
...  
Keyword(s):  
Pregnancy Loss ◽  
Fixed Time ◽  
P Value ◽  
Device Removal ◽  
Releasing Hormone ◽  
Condition Score ◽  
Gonadotrophin Releasing Hormone ◽  
To Receive ◽  
Angus Heifers ◽  
Intravaginal Device

Oestrus expression between progesterone (P4) withdrawal and fixed-time AI (FTAI) has been shown to improve pregnancies per AI (P/AI) by 27% in beef cattle. As a result, cattle that do not express oestrus after P4 withdrawal present a challenge to the efficiency of FTAI. The present study was designed to test the hypothesis that administration of gonadotrophin-releasing hormone (GnRH) at the time of AI in heifers that do not express oestrus can improve fertility. Two-year-old Angus heifers (n=1032) with a condition score of 2.75 to 3.5 at two locations in Argentina were used. On Day 0, heifers received an intravaginal device containing 0.5g of P4 (Cronipres, Biogenesis) and 2mg of oestradiol benzoate intramuscularly (Bioestrogen, Biogenesis). On Day 8, devices were removed and heifers received 150µg of d-cloprostenol intramuscularly (Enzaprost, Biogenesis), 0.5mg of oestradiol cipionate intramuscularly (Croni-Cip, Biogenesis), and an oestrus detection patch (Estrotect, Rockway Inc.). On Day 10, AI was performed in all heifers 50 to 54h after device removal. Heifers were categorised based on oestrus expression, and those that did not express oestrus were randomised to receive 100µg of gonadorelin acetate intramuscularly (Gonasyn, Syntex; n=158) concurrent with AI or remain as untreated controls (n=151). Pregnancy was determined using ultrasonography at Days 38 and 111 after AI. Differences in fertility were evaluated using generalised linear mixed models, and the results are shown in Table 1. Oestrus expression between device removal and FTAI was 70.1% (723/1032). Pregnancies per AI at Days 38 and 111 were different between groups (P<0.01). Heifers that expressed oestrus had greater P/AI than those that did not regardless of treatment (P<0.01). However, in heifers that did not express oestrus, treatment with GnRH at the time of AI resulted in greater P/AI than in control heifers (P=0.004). Similarly, P/AI at Day 111 were greater in heifers that expressed oestrus than in those that did not regardless of treatment (P<0.01). Heifers that did not express oestrus and were treated with GnRH had greater P/AI than those that did not express oestrus and remained as controls (P=0.02). Pregnancy loss between Days 38 and 111 was not different between groups; however, there was a tendency (P=0.06) for greater pregnancy loss in heifers that did not express oestrus and were treated with GnRH compared with heifers that expressed oestrus. In summary, treatment with GnRH at the time of AI is a suitable strategy to improve P/AI in heifers that fail to exhibit oestrus after an oestradiol-based synchronisation protocol. However, this strategy appears to increase pregnancy loss, and thus further research is needed to confirm this observation and the mechanisms underlying it. Table 1.Pregnancies per AI (P/AI) and pregnancy loss (%; no. in parentheses) in Angus heifers based on oestrus expression and treatment with GnRH Group P/AI Day 38 P/AI Day 111 Pregnancy loss Oestrus 68.9 (498/723)A 65.2 (471/723)A 5.4 (27/498) No oestrus control 29.8 (45/151)B 28.5 (43/151)B 4.4 (2/45) No oestrus + GnRH 45.6 (72/158)C 40.5 (64/158)C 11.1 (8/72) P-value <0.001 <0.001 0.15 A-CValues within a column with different superscripts differ significantly (P<0.05).

160 Increasing gonadotrophin-releasing hormone dose at initiation of a 5-day CO-Synch protocol increases ovulatory response but not fertility in yearling beef heifers

2020 ◽  
Vol 32 (2) ◽  
pp. 206
Author(s):  
E. Rojas Canadas ◽  
S. E. Battista ◽  
J. Kieffer ◽  
S. Wellert ◽  
A. Garcia Guerra
Keyword(s):  
Dose Group ◽  
Fixed Time ◽  
Ovulation Rate ◽  
Corpora Lutea ◽  
Double Dose ◽  
Device Removal ◽  
Beef Heifers ◽  
Releasing Hormone ◽  
Gonadotrophin Releasing Hormone ◽  
To Receive

Heifers typically have a reduced ovulation rate following gonadotrophin-releasing hormone (GnRH) application at initiation of a CO-Synch + controlled internal drug release (CIDR) protocol. Thus, the objective of the present study was to determine whether increasing the dose of GnRH at initiation of a 5-day CO-Synch protocol in beef heifers would improve ovulation rate and therefore increase pregnancies per AI (P/AI). Angus yearling heifers (n=299) at five locations in Ohio (United States) were randomised to receive either 100µg (single; n=149) or 200µg (double; n=150) of gonadorelin acetate (Gonabreed, Parnell) at initiation of a 5-day CO-Synch. On Day −8, heifers received a new intravaginal progesterone-releasing device (1.38g of progesterone; CIDR, Zoetis) and either a single or double dose of GnRH as described above. Five days later (Day −3), devices were removed, 1000µg of cloprostenol sodium (Estroplan, Parnell) was administered, and an oestrous detection patch was applied (Estrotect, Rockway Inc.). Sixty hours after device removal, AI was performed concurrently with the administration of 100µg of GnRH. Pregnancy was determined using ultrasonography 35 days after AI. Ovaries from a subset of animals (n=178) were examined on Days −8 and −3 using ultrasonography to determine the presence of corpora lutea (CL) and the size of the largest follicle. Data were analysed using the GLIMMIX procedure of SAS ver. 9.4 (SAS Institute Inc.). Oestrous expression was similar (P=0.50) between heifers treated with a single (49.0%) or double (52.7%) dose of GnRH. Overall, P/AI was similar (P=0.35) between heifers receiving a single (43.6%; 65/149) or double (38.7%; 58/150) dose of GnRH at initiation of the protocol. However, increasing the dose of GnRH resulted in a greater (P=0.04) ovulation rate in heifers in the double-dose group (40.9%; 36/88) compared with those in the single-dose group (26.1%; 23/88). In addition, heifers with a CL at the time of treatment had reduced ovulatory response to GnRH treatment (16.0%) compared with heifers without a CL (53.7%; P=0.001); however, there was no treatment×CL presence interaction (P=0.69). Heifers that did not ovulate to the initial GnRH treatment had a greater (P=0.0008) diameter of the largest follicle on Day −3 compared with heifers that did ovulate (11.4±0.2 vs. 10.0±0.3). Furthermore, heifers that did ovulate after the initial GnRH had greater (P=0.04) P/AI (52.5%) than heifers that did not ovulate (40.2%), and heifers with a CL on Day −8 tended (P=0.07) to have greater P/AI (47.9%) than heifers without a CL (40.2%). In addition, heifers with a CL present on Day −3 had greater (P=0.04) P/AI (48.2%) than heifers without a CL (31.7%). In summary, increasing the dose of GnRH at initiation of a 5-day CO-Synch did not affect fertility to fixed-time AI but enhanced ovulation rate in beef heifers. Furthermore, heifers that did ovulate at initiation of the protocol or that had a CL at device insertion or removal had greater fertility to fixed-time AI. Thus, alternative strategies that maximise ovulation at initiation of the synchronisation protocol are needed.

101 Treatment with gonadotrophin-releasing hormone on Day 7 or 21 does not reduce pregnancy loss in dairy heifers receiving invitro-produced embryos

2020 ◽  
Vol 32 (2) ◽  
pp. 176
Author(s):  
B. J. Duran ◽  
R. V. Sala ◽  
P. L. J. Monteiro ◽  
C. Gamarra ◽  
M. Fosado ◽  
...  
Keyword(s):  
Embryo Transfer ◽  
Pregnancy Loss ◽  
Body Condition Score ◽  
Prostaglandin F2α ◽  
P Value ◽  
Releasing Hormone ◽  
Dairy Heifers ◽  
Condition Score ◽  
Pregnancy Status ◽  
Gonadotrophin Releasing Hormone

Previous research has shown that induction of an accessory corpus luteum (CL) by administration of gonadotrophin-releasing hormone (GnRH) on Day 5 increases circulating progesterone and reduces pregnancy loss between Days 33 and 60 in heifers receiving invitro-produced (IVP) embryos. Therefore, the objective of the present study was to determine whether timing of induction of an accessory CL influenced pregnancy loss in IVP recipients. Holstein heifers (n=1,658) were synchronized using a modified 5-day CIDR CO-Synch protocol. Briefly, heifers received an intravaginal progesterone device (CIDR) on Day −8, Day −3: CIDR removed and first prostaglandin F2α (PGF2α) treatment, Day −2: second PGF2α, and Day 0: GnRH (G1, 100µg of gonadorelin acetate). Oestrus expression was evaluated on Day 0 with the use of an oestrus detection device. Transfer of fresh IVP embryos was performed on Day 7±1 after G1. At the time of transfer, heifers were randomly assigned, in a 2×2 factorial design, to receive GnRH (200µg of gonadorelin acetate) or remain as Control (untreated) at two different times: Day 7 (time of embryo transfer (ET)) or Day 21. Thus, the following groups were formed: Control-Control (n=410); Control-GnRH (n=409); GnRH-Control (n=419); and GnRH-GnRH (n=420). All heifers were evaluated by transrectal ultrasonography to determine number, size, and location of CL on Days 5, 14, 21, 28, 32, and 60 and pregnancy status on Days 28, 32, and 60. Data collected from each heifer included embryo stage and quality, oestrus expression, body condition score, number of transfers, and technician. Pregnancies per embryo transfer (P/ET) and pregnancy loss data were analysed by logistic regression (SAS 9.4). Ovulation to Day 7 treatment was greater (P<0.01) in GnRH treated heifers (70.0%; 585 out of 836) than in untreated Controls (2.7%; 22 of 819). Ovulation to Day 21 treatment was determined only in animals pregnant at Day 28 and was greater (P<0.01) in heifers treated with GnRH (37.6%; 153 of 407) than in untreated controls (1.0%; 4 of 390). There was no effect of Day 7 treatment (P>0.68) or Day 21 treatment (P>0.18), nor a Day 7×Day 21 treatment interaction (P>0.48) on P/ET at Day 32 or 60 (Table 1). Treatment with GnRH on Day 7 or 21 did not alter pregnancy loss between Days 32 and 60 (P>0.10). Heifers with an accessory CL present at Day 32 (11.7%; 41 of 350) had similar (P=0.55) pregnancy loss compared with heifers with no accessory CL (14.4%; 54 of 375). The number of CL present on Day 32 did not affect (P=0.23) pregnancy loss; however, heifers with 3 CL (4.9%; 3 of 61) tended (P<0.10) to have reduced pregnancy loss compared with heifers with 1 CL (14.4%; 54 of 375) or 2 CL (13.2%; 38 of 289). In conclusion, treatment with GnRH on Day 7 or 21 induced an accessory CL; however, it did not affect P/ET on Days 32 or 60 and pregnancy loss. Table 1.Pregnancies per embryo transfer (P/ET) and pregnancy loss in embryo recipients based on timing of treatment with gonadotrophin-releasing hormone (GnRH) Treatment P/ET Day 32% (n) P/ET Day 60% (n) Pregnancy loss% (n) Day 7 Day 21 Control Control 42.4 (410) 36.1 (410) 15.0 (174) GnRH 46.0 (409) 40.7 (409) 11.7 (188) GnRH Control 43.7 (419) 36.8 (419) 15.9 (183) P-value GnRH 43.1 (420) 38.8 (420) 10.0 (181) Day 7 treatment 0.68 0.72 0.96 Day 21 treatment 0.51 0.18 0.11 Interaction 0.48 0.66 0.71

scholarly journals Development of fixed-time artificial insemination protocols for locally adapted Curraleiro Pé-Duro cows

2016 ◽  
Vol 68 (5) ◽  
pp. 1159-1167 ◽  
Author(s):  
R.D. Tortorella ◽  
M.R. Modesto ◽  
J.P. Neves ◽  
A.F. Ramos
Keyword(s):  
Body Condition Score ◽  
Hormonal Treatment ◽  
Fixed Time ◽  
Estradiol Benzoate ◽  
Device Removal ◽  
Condition Score ◽  
Equine Chorionic Gonadotropin ◽  
Hot Environments ◽  
To Receive ◽  
Intravaginal Device

ABSTRACT Two experiments were conducted aiming to evaluate the effects of two ovulatory inducers (Exp.1) and equine chorionic gonadotropin (eCG; Exp.2) on follicular and luteal dynamics in a fixed-time AI (FTAI) protocol in locally adapted Curraleiro Pé-Duro cows. In Exp. 1 multiparous cows (n=12) received an intravaginal device containing 1g of progesterone (P4) for 8 days and 2mg of estradiol benzoate (EB) intramuscularly (IM) at device insertion (Day 0). At device removal (Day 8) 0.150mg of Sodium D-Cloprostenol was administered IM and the cows were randomly assigned to receive 1mg of EB (EB8) or 1mg of estradiol cypionate (EC8) IM, or to not receive any ovulatory inducer (Control). All the animals participated in all treatments (crossover). The interval from P4 removal to ovulation was shorter and less variable in the EB8 treatment group (P≤0.05). In Exp. 2 (crossover), multiparous cows (n=12) received the same hormonal treatment as the EB8 group in Exp.1. At device removal (Day 8) cows were randomly assigned to receive 300UI of eCG IM or to not receive eCG (Control). No difference was ascertained on follicular and luteal parameters in Exp. 2 (P>0.05). We concluded that EB can be used as the ovulatory inducer (Exp. 1) in a FTAI protocol in Curraleiro Pé-Duro cows. However, eCG (Exp. 2) was not able to stimulate follicular and luteal development. This result is probably due to the adaptive capacity of Curraleiro Pé-Duro cows that maintained a satisfactory body condition score even in dry and hot environments.

7 PREGNANCY RATES IN BEEF HEIFERS SYNCHRONIZED WITH A SHORTENED OESTRADIOL-BASED TREATMENT THAT PROVIDES FOR A PROLONGED PROESTRUS

2015 ◽  
Vol 27 (1) ◽  
pp. 96 ◽  
Author(s):  
A. Menchaca ◽  
R. Nuñez-Olivera ◽  
F. Cuadro ◽  
G. Bo
Keyword(s):  
Treatment Group ◽  
Day Treatment ◽  
Fixed Time ◽  
Gonadotropin Releasing Hormone ◽  
Pregnancy Rates ◽  
Device Removal ◽  
Beef Heifers ◽  
Releasing Hormone ◽  
Secondary Objective ◽  
To Receive

An oestradiol-based protocol (named J-Synch) has been developed recently with the aim of providing for a longer proestrus, enhancing the development of the dominant follicle before ovulation, and increasing pregnancy rates following fixed-time AI (FTAI) in heifers (de la Matta and Bo 2012 Taurus 55, 17–23). Two experiments were performed in Uruguay with 1953 Angus × Hereford crossbred heifers to compare pregnancy rates obtained with the J-Synch protocol with the conventional 7-day oestradiol-based protocol. A secondary objective was to determine the effects of the time of FTAI and the addition of eCG at the time progestin device removal on pregnancy rates. In Experiment 1, 966 heifers received a DIB device (0.5 g of progesterone, Syntex, Buenos Aires, Argentina) plus 2 mg of oestradiol benzoate IM (Syntex) on Day 0. Heifers in the conventional treatment group (n = 485) received cloprostenol (500 μg, Ciclase DL, Syntex) and oestradiol cypionate (0.5 mg, Cipiosyn, Syntex) IM and had their DIB removed on Day 7 a.m. Heifers in this group were then subdivided to be FTAI on Day 9 a.m. or p.m. (i.e. 48 or 56 h after DIB removal). Heifers in the J-Synch treatment group (n = 481) received cloprostenol IM and DIB removal on Day 6 p.m. and received gonadotropin-releasing hormone (100 μg gonadorelin acetate, Gonasyn Gdr, Syntex) on Day 9 a.m.; heifers were then FTAI on Day 9 a.m. or p.m. (i.e. 60 or 72 h after DIB removal). All heifers in this experiment were also treated with 300 IU of eCG (Novormon, Syntex) at DIB removal. In Experiment 2, 987 heifers were treated with the J-Synch protocol as described in Experiment 1. At device removal (Day 6 p.m.), heifers were divided to receive (n = 488) or not (n = 499) 300 IU of eCG IM at that time and were further subdivided to receive gonadotropin-releasing hormone and FTAI on Day 9 a.m. or p.m. (i.e. 60 or 72 h after DIB removal). Pregnancy rates were determined by ultrasonography 30 days after FTAI. Data were analysed using logistic regression, and results are shown in Table 1. J-Synch-treated heifers tended (P < 0.1) to have higher pregnancy rates following FTAI, whereas time of FTAI only affected pregnancy rates following the conventional 7-day treatment (P < 0.05). However, removal of eCG from the J-Synch protocol in Experiment 2 resulted in reduced pregnancy rates when inseminations were done on Day 9 p.m. (P < 0.05). In summary, the addition of eCG to the J-Synch protocol provided for a wider window of insemination times facilitating FTAI in large groups of beef heifers. Table 1.Effect of length of progestin insertion, time of insemination and eCG treatment on pregnancy rates in beef heifers

8 EFFECT OF SEMEN TYPES (SEXED v. NONSEXED) ON CONCEPTION RATES OF GIROLANDO HEIFERS INSEMINATED IN FIXED-TIME AI

2010 ◽  
Vol 22 (1) ◽  
pp. 162
Author(s):  
J. Almeida ◽  
O. A. Resende ◽  
D. L. Silveira
Keyword(s):  
Body Condition Score ◽  
Fixed Time ◽  
Estradiol Benzoate ◽  
Sao Paulo ◽  
São Paulo ◽  
Device Removal ◽  
Conception Rates ◽  
Sexed Semen ◽  
Condition Score ◽  
Intravaginal Device

With the goal of optimizing protocols, fixed-time artificial insemination (FTAI) was performed under field conditions in a study to evaluate conception rates in Girolando (5/8) heifers (18 to 24 months of age) treated with estradiol benzoate (BE) to induce ovulation. Forty heifers were allocated to 2 groups with 20 animals each: GI-sexed semen (2 million spermatozoa/dose) and GII-nonsexed semen (20 million spermatozoa/dose), with body condition score (BCS) of 3.0 ± 0.14 (scale of 1 to 5), middleweight of 335 ± 38 kg, so that it was made for reutilization of progesterone device. On Day 0 (morning), the animals received 2.0 mg of BE (RIC-BE®,Tecnopec, São Paulo, Brazil), 0.075 mg of D-cloprostenol (Prolise®, ARSA S.R.L., Buenos Aires, Argentina), and an intravaginal device of 1 g of progesterone (Primer®, Tecnopec). On Day 8 (morning) the device was removed and 0.075 mg of D-cloprostenol was managed in the GI animals, then these animals received 1.0 mg of BE 24 h after device removal. The insemination was in the late afternoon of Day 10 with a 6-hour delay (4 to 6 pm). The GII animals received Primer previously used for 8 days (being used in the GI animals under the same protocol). After pregnancy diagnosis at 60 days, a third group was created (GIII) using the not-pregnant animals of GI and GII. In GIII, Primer from third use [disinfected in solution Kilol®-L 1:250 (Quinabra, São Paulo, Brazil) and rinsed with water, dried, and packed in plastic sacks and kept for 60 days] was used following the GI protocol with sexed semen. There were no significant differences (P > 0.05) in the conception rates of 40, 58, and 65% among groups GI (8/20), GII (11/20), and GIII (13/20). These results indicate very good conception rates for heifers, contrary to recommendations of commercial companies of sexed semen that alert for the conception rate for mated animals to be lower when using FTAI and mating protocols in mass, compared with that of AI after estrus observation.

178 USE OF A NEW INTRAVAGINAL DEVICE TO RELEASE PROGESTERONE IN FIXED-TIME EMBRYO TRANSFER EMBRYO RECIPIENTS

2010 ◽  
Vol 22 (1) ◽  
pp. 247
Author(s):  
J. R. V. Pimentel ◽  
P. H. P. Miguez ◽  
A. Kehrle ◽  
E. H. Madureira ◽  
F. A. Braga ◽  
...  
Keyword(s):  
Embryo Transfer ◽  
Body Condition Score ◽  
Block Design ◽  
Fixed Time ◽  
Estradiol Benzoate ◽  
Sao Paulo ◽  
P Value ◽  
São Paulo ◽  
Condition Score ◽  
Intravaginal Device

Progestagen-releasing devices are commonly used for fixed-time artificial insemination and fixed-time embryo transfer (FTET). The aim of this study was to evaluate the efficacy of a new progesterone-releasing intravaginal device made of poly(3-hydroxy)butyrate-valerate copolymer (PHB-V) and poly-ϵ-caprolactone (PCL; Progestar®, Innovare, São Paulo, Brazil) to synchronize crossbredcows and heifers for FTET by determining ovulation, conception, and pregnancy rates. A total of 205 recipients ranging in age from 2 to 8 years (heifers, n = 77; non-suckled cows, n = 69; suckled cows, n = 59) were used on 3 different farms during February, March, and April 2008. The experimental design was a generalized block design (cyclicity, body condition score, postpartum interval, and animal category, i.e. heifers, suckled, or non-suckled cows), with 2 different synchronization treatments for FTET (Progestar® v. Crestar®). Cows were assigned to either Crestar® (norgestomet ear implants; Intervet Schering-Plough, Kenilworth, NJ, USA; n = 103) or Progestar® (PHB-V; n = 102) treatments. All groups were treated with 2 mg of estradiol benzoate i.m. (Innovare) and received the intravaginal or auricular device according to their group (Day 0). Together with P4 device withdrawal (Day 8), all animals received 400 IU of eCG i.m. (Novormon®, Schering-Plough) and 500 μg i.m. of PGF2α, (Sincrocio®, Ouro Fino, Brasil). On Day 9, all cows were treated with 1 mg of estradiol benzoate (Innovare) and the innovulation was performed on Day 17. Embryos were maintained at 37°C during the innovulation period. The percentage of usable recipients (AR) based on the presence of a functional CL on the day of embryo transfer, conception rate (numbers of pregnant recipients of the total number transferred; CR), and pregnancy rate (numbers of pregnant recipients of the total number synchronized; PR) were determined by ultrasonography 23 days after embryo transfer. Data were submitted to ANOVA (PROC GLM, SAS Institute Inc., Cary, NC, USA) and significant differences were considered to have a P-value of <0.05. None of the interactions were significant and there was no effect of treatment on AR (72.8% v. 83.3%), CR (47.9% v. 42.7%), and PR (34.7% v. 35.0%) for Progestar® v. Crestar® groups, respectively. This experiment showed that Progestar® was as efficacious as Crestar® to synchronize crossbred cows and heifers for FTET. FAPESP-Fundação de Amparo à Pesquisa do Estado de São Paulo and CNPq-Conselho Nacional de Desenvolvimento Científico e Tecnológico.

109 Pre-synchronization and reutilization of progesterone devices during a 6-day CO-Synch protocol for fixed-time artificial insemination in beef heifers

2021 ◽  
Vol 33 (2) ◽  
pp. 161
Author(s):  
E. R. Canadas ◽  
B. J. Duran ◽  
G. Machado ◽  
A. Nall ◽  
S. E. Battista ◽  
...  
Keyword(s):  
Artificial Insemination ◽  
Mixed Models ◽  
Generalized Linear Mixed Models ◽  
Fixed Time ◽  
P Value ◽  
Beef Heifers ◽  
Follicle Diameter ◽  
Follicle Size ◽  
Gonadotrophin Releasing Hormone ◽  
Intravaginal Device

Ovulatory response to the initial gonadotrophin-releasing hormone (GnRH) of the CO-Synch protocol is affected by circulating progesterone (P4) and follicle size. In addition, heifers that ovulate to the initial GnRH treatment have greater fertility after AI. Thus, this study determined the effect of (1) presynchronization (Presynch) before a 6-day CO-Synch protocol and (2) circulating [RCE1] (P4) on ovulatory response, oestrus expression, and pregnancies per AI (P/AI) in beef heifers. Yearling beef heifers (n=233) at three locations were randomly assigned in a 2×2 factorial design to the following treatments: (1) Presynch+6-day CO-Synch with a new P4 device; (2) Presynch+6-day CO-Synch with a once-used P4 device; (3) 6-day CO-Synch with a new P4 device; and (4) 6-day CO-Synch with a once-used P4 device. Presynch consisted of insertion of a new P4 intravaginal device (1.38g of P4) on Day −17 and removal of P4 device on Day −11 concurrently with 500µg of cloprostenol sodium (PGF). On Day −9, all heifers received either a new (New) or once-used (Used) CIDR and 100µg of gonadorelin acetate (GnRH). Six days later (Day −3), CIDRs were removed, 1000µg of PGF was administered and an oestrous detection patch applied (Estrotect). At 72h after CIDR removal, AI was performed concurrently with administration of 100µg of GnRH. Pregnancy was determined by transrectal ultrasonography 31 days after AI. A subset of heifers (n=155) was examined on Day −9 and Day −3 by ultrasonography to determine ovulation to Day −9 GnRH. Data were analysed using generalized linear mixed models (SAS 9.4; SAS Institute Inc.). Presynch heifers had larger follicle diameter on Day −9 (12.7±0.3 vs. 10.1±0.3 mm; P&lt;0.001), greater ovulatory response to Day −9 GnRH (82.5%; 66/80 vs. 56%; 42/75; P&lt;0.001), greater expression of oestrus (90.6%; 106/117 vs. 78.4%; 91/116; P&lt;0.02), and earlier oestrus (49.8±1 vs. 53.1±1 h; P&lt;0.01) compared with controls. There was a treatment×CIDR interaction on oestrous expression, such that a lesser (P&lt;0.05) percentage of control heifers with new CIDR expressed oestrus compared with all other groups (Table 1). Heifers with a used CIDR during the 6-day CO-Synch tended (P=0.08) to have greater P/AI (52.1%; 61/117) than those with a new CIDR (40.5%; 47/116). In conclusion, presynchronization before initiation of a 6-day CO-Synch increased follicle diameter, enhanced ovulatory response and oestrous expression, but did not affect fertility. The earlier onset of oestrus in presynchronized heifers suggests that the timing of AI may need to be modified. Table 1. Oestrous expression and pregnancy per AI (P/AI) in beef heifers with or without presynchronization and treated with a new or used CIDR during a 6-day CO-Synch Treatment CIDR Oestrus (%; n/n) Time of oestrus (h) P/AI (%; n/n) Control New 67.8a (40/59) 53.7±1.5a 33.9 (20/59) Used 89.5b (51/57) 52.7±1.6a 50.9 (29/57) Presynch New 94.7b (54/57) 50.9±1.4b 47.4 (27/57) Used 86.7b (52/60) 48.7±1.3b 53.3 (32/60) P-value Treatment 0.03 0.01 0.21 CIDR 0.62 0.19 0.08 Interaction 0.003 0.75 0.38 a,bValues with different superscripts differ (P&lt;0.05).

7 INFLUENCE OF ESTRUS EXPRESSION AND TREATMENT WITH GnRH ON PREGNANCY RATES IN BEEF CATTLE SYNCHRONIZED WITH PROGESTERONE DEVICES AND ESTRADIOL AND INSEMINATED AT A FIXED-TIME

2017 ◽  
Vol 29 (1) ◽  
pp. 111 ◽  
Author(s):  
G. A. Bó ◽  
A. Cedeño ◽  
A. Tribulo ◽  
S. Andrada ◽  
R. Tribulo ◽  
...  
Keyword(s):  
Logistic Regression ◽  
Beef Cattle ◽  
Body Condition Score ◽  
Fixed Time ◽  
Beef Cows ◽  
Pregnancy Rates ◽  
Device Removal ◽  
Oestradiol Benzoate ◽  
Condition Score ◽  
To Receive

We have previously shown that expression of oestrus significantly influences the time of ovulation and pregnancy rates to timed-AI (P/TAI) in beef cattle synchronized with progesterone devices and oestradiol (Bó et al. 2016 Theriogenology 86, 388–396). Furthermore, delaying TAI from 48 h to 54–58 h after device removal improved P/TAI of those animals not showing oestrus by 48 h. The objective of the present study was to determine whether the administration of GnRH to those animals not showing oestrus by 48 h after device removal had an impact on P/TAI. Non-lactating and suckled beef cows and heifers (Bonsmara, Brangus, and Braford; n = 868), with a corpus luteum (CL) or a follicle ≥8 mm in diameter detected by ultrasonography (Mindray DP 30 Vet, 7.5 MHz, China) and body condition score 2 to 4 (1 to 5 scale) were synchronized in 3 replicates. On Day 0, animals received a progesterone device (DIB 0.5 g, Zoetis, Argentina) and 2 mg of oestradiol benzoate (Von Franken, Argentina). On Day 8, DIB were removed and cows received 0.150 mg of D+cloprostenol (Río de Janeiro, Argentina) plus 0.5 mg oestradiol cypionate (Cipiosyn, Zoetis). In addition, all cows were tail-painted on the sacrococcygeal area (CeloTest, Biotay, Argentina) at DIB removal and were observed to determine the expression of oestrus, according to the percentage of paint loss (PL) 48 h later. The animals that showed oestrus (PL > 30%) were recorded and TAI at that time while those with PL ≤ 30% (not in oestrus) were randomly allocated to receive 100 μg of gonadorelin (GnRH; Gonasyn, Zoetis) or no treatment and TAI between 54 to 58 h after DIB removal. Pregnancy was diagnosed by ultrasonography at 45 days after TAI, and data were analysed by logistic regression. There were no significant differences among replicates, inseminators, semen source or animal class (dry cows, suckled cows or heifers; P > 0.11). However, animals showing oestrus by 48 h after DIB removal had higher P/TAI (371/666; 55.7; P < 0.04) than those that did not show oestrus (96/202; 47.5%). Within animals not showing oestrus at 48 h, those that were in oestrus by the TAI at 54 to 58 h had higher P/TAI (71/124, 57.3%; P < 0.01) than those that did not show oestrus within that period (27/78; 34.6%). In addition, P/TAI was higher (P < 0.01) in animals that received GnRH (66/113; 58.4%) than in those that did not receive GnRH (30/89; 33.7%). In conclusion, the expression of oestrus significantly affected P/TAI in beef cattle synchronized with progesterone devices and oestradiol. Furthermore, treatment of animals not showing oestrus by 48 h after DIB removal with GnRH resulted in improved P/TAI performed 6 to 10 h later.

12 OVARIAN STRUCTURES, ESTRUS EXPRESSION, AND PREGNANCY RATE IN BEEF HEIFERS USING ESTRADIOL CYPIONATE OR GnRH AS OVULATION INDUCTORS IN TIMED AI PROTOCOL

2017 ◽  
Vol 29 (1) ◽  
pp. 113 ◽  
Author(s):  
E. Pradebon da Silva ◽  
A. B. Machado ◽  
L. S. Gambin ◽  
A. V. Gonsioroski ◽  
M. da Silva ◽  
...  
Keyword(s):  
Pregnancy Rate ◽  
Body Condition Score ◽  
Device Removal ◽  
Treatment Groups ◽  
Follicle Diameter ◽  
Ovulatory Follicle ◽  
Condition Score ◽  
In The Beginning ◽  
Angus Heifers ◽  
Intravaginal Device

The aim of this study was to evaluate the effect of presence of corpus luteum (CL) at the onset of timed AI (TAI) protocol, size of ovulatory follicle and oestrus expression on pregnancy rate using E2 cypionate (EC) or GnRH as ovulation inductor in Angus heifers. On day 0, heifers [n = 414; 317 ± 23 kg; 3.08 ± 0.21 body condition score (1 to 5 scale) and 22–24 months of age] received a 1-g progesterone intravaginal device (Primer®, Agener União, Brazil) and 2 mg of oestradiol benzoate, IM, (RIC-BE®, Agener União, Brazil). On day 8, the device was removed, were administered 500 μg of sodium cloprostenol, IM, (Estron®, Agener União, Brazil) and heifers were divided in 2 groups: EC [n = 213; 0.5mg EC, IM, (SincroCP®, Ouro Fino, Brazil) on day 8] and GnRH [n = 201; 25 μg of Licerelin, IM, (GestranPlus®, Agener União, Brazil) at TAI] TAI was performed 50 h after device removal. Heifers were tail painted (Tell Tail®, GEA, New Zealand) to control oestrus expression from device removal to TAI. Heifers were scanned (7.5-MHz linear transducer MediSono® P3V, USA) to determine presence of CL (Day 0), ovulatory follicle diameter (OFD; Day 10) and ovulation (Day 11). Pregnancy was diagnosed 30 days after TAI. Oestrus expression was confirmed when marking ink was removed on day 10. Data were analysed using logistic regression and ANOVA. Oestrus expression was higher (P < 0.05) in EC (93.90%, 200/213) compared to GnRH group (67.66%, 136/201). The OFD differed (P < 0.05) according to presence of CL on Day 0 (10.3 mm) or not (9.6 mm), but was similar in treatment groups. Ovulation rate did not differ in EC (85%, 17/20) and GnRH (95%, 19/20) groups. Pregnancy rates were similar (P > 0.05) between EC (52.58%, 112/213) and GnRH (59.20%, 119/201) groups; however, in heifers that expressed oestrus, rates were higher (P < 0.05) (EC = 56%, 112/200; GnRH = 71.3%, 97/136) than in those did not show (EC = 0%, 0/13; GnRH = 33.8%, 22/65). Presence of CL at onset of TAI protocol was associated with higher pregnancy (P < 0.05) in GnRH group (68%, 68/100) compared with EC (54.46%, 61/112) group, but in heifers without CL, pregnancy were similar for GnRH (50.5%, 51/101) and EC (50.5%, 51/101) groups. Heifers were also classified in 3 groups according OFD: small (≤9.5 mm), medium (9.6–11.5 mm), and large (≥11.6 mm) to verify its effect on oestrus expression and pregnancy. Medium and large OFD were implicated in higher (P < 0.05) oestrus expression [(EC = 100%, 51/51; 96.97%, 32/33) and (GnRH = 83.02%, 44/53; 97.44%, 38/39)] than small OFD [(EC = 85%, 51/60) and (GnRH = 23.8%, 15/63)]. Pregnancy was lower (P < 0.05) in small OFD groups (EC = 28.3%, 17/60; GnRH = 25.4%, 16/63). In medium and large OFD, pregnancy was similar in EC (72.55%, 37/51; 54.55%, 18/33) groups, but differed (P < 0.05) between GnRH large (82.05%, 32/39) and medium (62.26%, 33/53). Higher pregnancy was achieved in heifers with CL in the beginning of TAI protocol treated with GnRH. Size of ovulatory follicle was associated with higher oestrus behaviour and pregnancy rate in EC and GnRH treatments.

113 Different doses of equine chorionic gonadotrophin on pregnancy and twin rates of Bos taurus beef heifers subjected to J-Synch protocol for fixed-time artificial insemination

2021 ◽  
Vol 33 (2) ◽  
pp. 164
Author(s):  
C. G. Pintos ◽  
R. Núñez-Olivera ◽  
F. Cuadro ◽  
C. Brochado ◽  
G. A. Bó ◽  
...  
Keyword(s):  
Bos Taurus ◽  
Body Condition Score ◽  
Fixed Time ◽  
Chorionic Gonadotrophin ◽  
P Value ◽  
Device Removal ◽  
Beef Heifers ◽  
Buserelin Acetate ◽  
Condition Score ◽  
Different Doses

The objective was to evaluate the effect of different doses of equine chorionic gonadotrophin (eCG) on pregnancy (P/AI) and twin rates of beef heifers in a progesterone and oestradiol-based treatment (J-Synch protocol) for fixed-time AI (FTAI). A total of 1,404 Bos taurus beef heifers with a body condition score 4.8±0.5 (mean±s.e.m., scale 1–8) were used in three different locations. The presence of a corpus luteum (CL) was determined by ovarian ultrasonography (5.0MHz) at the beginning of the J-Synch protocol. On Day 0, the heifers received 2mg of oestradiol benzoate (intramuscular, IM) associated with an intravaginal device containing 0.5g of progesterone. At device removal, on Day 6, 500µg of cloprostenol sodium was administered IM and the females were randomly assigned to one of two experimental groups to receive 200 (n=702) or 300 (n=702) IU of eCG (Zoetis) IM. Heifers were also tail-painted. On Day 0 females with paint rubbed-off were FTAI 64 h after device removal, and those that remained with the paint received 8 μg of buserelin acetate 64 h after device removal to be FTAI 8 h later. FTAI was performed at 64 to 72h after device removal, and pregnancy diagnosis was performed by ultrasonography 30 to 35 days after insemination. Data were analysed by logistic regression using GLMM. The results are shown in Table 1. Pregnancy rate was not different between heifers treated with 200 or 300IU of eCG (P=0.513) and was not affected by the presence of CL at the beginning of the protocol (P=0.513). Twin rate was greater in heifers treated with 300IU than with 200IU of eCG (P=0.005), and it was not affected by the presence of CL (P=0.362). Interaction between eCG treatment and presence of CL was not significant for pregnancy or twin rates (P=0.532). In conclusion, although 300IU of eCG increased the twin rate compared with 200IU, no differences were found in P/AI. We suggest that the dose of eCG in the J-Synch protocol could be adjusted to 200IU in Bos taurus beef heifers. Table 1. Pregnancy per AI (P/AI) and twin rates obtained with different doses of eCG (200 or 300IU) in a J-Synch protocol for fixed-time AI in cycling (CL) and anestrous (no CL) Bos taurus beef heifers Variable 200 IU 300 IU P-value CL no CL Total CL No CL Total eCG CL eCG×CL P/AI (%) 61.6% (135/219) 59.8% (289/483) 60.4% (424/702) 60.2% (133/221) 59.5% (286/481) 59.7% (419/702) 0.513 0.513 0.513 Twin rate (%) 3.0% (4/135) 3.5% (10/289) 3.3% (14/424) 6.8% (9/133) 9.4% (27/286) 8.6% (36/419) 0.005 0.362 0.532

Sign in / Sign up

Export Citation Format

Share Document